EMA validates Pfizer and Valneva’s Lyme disease vaccine
The submission is supported by efficacy and safety data from the Phase III VALOR clinical trial.
Drug Development
FDA grants fast track status to Phanes’ spevatamig for advanced BTC
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma
Xanadu and University of Alberta to develop quantum algorithms for cancer
Akeso secures China NMPA authorisation for ivonescimab combo
Remepy secures $36m funding for hybrid drug pipeline expansion
Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat
Alfasigma signs agreement to acquire Nordic Group
